# Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia

> **NCT00947830** · — · COMPLETED · sponsor: **Brian Leber** · enrollment: 81 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00947830
- **Lead sponsor:** Brian Leber
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2013-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947830, "Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00947830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*